Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
IVERIC bio Inc.

Start price
Target price
Perf. (%)
€23.20
02.03.23
€33.06
02.03.24
56.90%
03.03.24

HC Wainwright 
02.03.23 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€23.20
02.03.23
€30.22
02.03.24
69.83%
03.03.24

Needham & Company LLC 
02.03.23 50%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€7.79
19.02.24
€6.00
16.05.26
-69.17%
03.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 60%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€40.60
01.03.23
€54.33
01.03.24
63.79%
02.03.24

Needham & Company LLC 
01.03.23 50%
buy
Seagen Inc.

Start price
Target price
Perf. (%)
€167.56
28.02.23
€159.97
28.02.24
25.57%
29.02.24

Guggenheim 
28.02.23 50%
buy
Krystal Biotech

Start price
Target price
Perf. (%)
€77.50
28.02.23
€95.04
28.02.24
93.55%
29.02.24

Guggenheim 
28.02.23 50%
sell
Nektar Therapeutics

Start price
Target price
Perf. (%)
€1.32
28.02.23
€1.88
28.02.24
-50.72%
29.02.24

The Goldman Sachs Group, Inc. 
28.02.23 50%
buy
UCB S.A.

Start price
Target price
Perf. (%)
€80.98
22.02.23
€95.00
22.02.24
18.18%
23.02.24

Could be worthwhile Investment >10% per year
melinda 
22.02.23 50%
buy
Carl Zeiss Meditec AG

Start price
Target price
Perf. (%)
€109.75
12.02.24
€112.00
12.02.25
2.05%
20.02.24

Traumtanz 
12.02.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€0.88
25.01.24
€1.30
25.01.25
143.18%
19.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
25.01.24 50%
buy
Cymabay Therapeutics Inc

Start price
Target price
Perf. (%)
€15.70
12.11.23
€20.00
31.03.26
89.81%
17.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
12.11.23 70%
sell
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.25
03.02.24
€1.00
03.02.25
-44.24%
17.02.24

mixitrader 
03.02.24 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.55
14.12.23
€3.00
14.12.24
128.19%
09.02.24

Marianka 
14.12.23 70%
buy
Carbylan Therapeutics Inc

Start price
Target price
Perf. (%)
€8.10
27.06.23
€12.00
31.07.26
74.07%
04.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
27.06.23 60%
sell
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€1.19
20.01.24
€1.00
20.01.25
-25.08%
03.02.24

nvestor 
20.01.24 50%
buy
Kura Oncology Inc

Start price
Target price
Perf. (%)
€17.70
25.01.24
€16.00
31.08.25
9.60%
02.02.24

Could be very worthwhile Investment >20% year
BiotechBee 
25.01.24 70%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€37.02
26.01.24
€38.00
26.01.25
7.05%
26.01.24

Traumtanz 
26.01.24 50%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€34.98
29.12.23
€36.00
29.12.24
5.83%
26.01.24

Traumtanz 
29.12.23 50%
sell
Novavax Inc.

Start price
Target price
Perf. (%)
€11.01
11.01.23
€6.00
11.01.24
-61.64%
12.01.24

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
geldnutzer 
11.01.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€529.00
18.12.23
€558.00
18.12.24
6.62%
06.01.24

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
18.12.23 50%
buy
Exact Sciences

Start price
Target price
Perf. (%)
€62.80
20.04.23
€65.50
03.05.24
9.71%
27.12.23

Solomon 
20.04.23 90%
sell
Takara Bio Inc.

Start price
Target price
Perf. (%)
€11.50
19.04.23
€11.20
19.04.24
-35.65%
27.12.23

Solomon 
19.04.23 0%
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.44
02.12.23
€2.00
02.12.24
-1.29%
05.12.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Traumtanz 
02.12.23 50%
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€24.15
30.11.23
€25.00
30.11.24
8.94%
05.12.23

Traumtanz 
30.11.23 50%
buy
MicroVision Inc

Start price
Target price
Perf. (%)
€2.36
29.11.23
€2.00
29.11.24
3.49%
02.12.23

Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Traumtanz 
29.11.23 50%